Apolipoprotein A-I-containing particles and reverse cholesterol transport in IDDM

Area of Science:

• Cardiovascular Science
• Metabolic Disorders
• Lipid Metabolism

Background:

• High-density lipoproteins (HDL) containing apolipoprotein A-I (apoA-I) protect against atherosclerosis by facilitating cholesterol efflux and reverse cholesterol transport.
• Previous research indicates that in vitro nonenzymatic glycosylation of HDL diminishes its capacity for cholesterol efflux via HDL receptors.

Purpose of the Study:

• To investigate the impact of glycosylation on the cholesterol efflux properties of lipoprotein A-I (Lp A-I) particles isolated from diabetic patients.
• To compare Lp A-I from diabetic and non-diabetic individuals regarding lipid composition and cholesterol efflux promotion.

Main Methods:

• Isolation of Lp A-I particles from two poorly controlled insulin-dependent diabetic patients and two matched non-diabetic control subjects.
• Analysis of lipid composition and assessment of the ability to promote cholesterol efflux from cultured adipose cells.
• Separation of Lp A-I from diabetic subjects based on the degree of glycosylation.

Main Results:

• No significant differences in lipid composition or cholesterol efflux capacity were observed between Lp A-I from diabetic and non-diabetic subjects overall.
• When fractionated by glycosylation, Lp A-I from diabetic subjects showed that glycosylated subfractions were approximately 50% less effective in promoting cholesterol efflux compared to non-glycosylated particles.

Conclusions:

• Nonenzymatic glycosylation of Lp A-I in poorly controlled diabetes significantly impairs its function in promoting cellular cholesterol efflux.
• These findings highlight a specific mechanism by which diabetes may compromise the atheroprotective functions of HDL particles, particularly Lp A-I.